Trials / Recruiting
RecruitingNCT07265999
Severity Factors of Dermatomyositis in the Caribbean Population - DM-ANTILLES
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 10 (estimated)
- Sponsor
- Centre Hospitalier Universitaire de la Guadeloupe · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
Dermatomyositis is a rare chronic autoimmune and inflammatory disease that affects the skin and striated muscles. Its prognosis is linked to visceral involvement (lungs, heart, and oropharyngeal region) and to the possible presence of associated cancer. The implementation of the research will allow identification of incident cases of dermatomyositis in Guadeloupe and the characterization of the disease in the overseas population, in the absence of data in the literature.
Detailed description
In the French West Indies, this condition is associated with high short- and medium-term morbidity and mortality. Diagnostic delays and patient care pathways may help explain this. However, a particularly severe phenotype of the disease in Antillean patients may also play a role, as observed in other autoimmune and inflammatory diseases we have described in overseas populations (e.g., systemic sclerosis, sarcoidosis). Identifying factors associated with the severity of dermatomyositis at the time of diagnosis would allow for the early implementation of a tailored management strategy to improve the disease prognosis in the target population.
Conditions
Timeline
- Start date
- 2021-07-16
- Primary completion
- 2029-07-16
- Completion
- 2029-07-16
- First posted
- 2025-12-05
- Last updated
- 2025-12-05
Locations
1 site across 1 country: Guadeloupe
Source: ClinicalTrials.gov record NCT07265999. Inclusion in this directory is not an endorsement.